Listed

BWX Technologies, Inc.: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 7, 2022 and accepted by EDGAR at Nov 7, 2022, 16:35 ET.

Share

Management's discussion and analysis

As filed, 45,149 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 in Part I of this quarterly report on Form 10-Q ("Report"), as well as the audited consolidated financial statements and the related notes and Item 7 of our annual report on Form 10-K for the year ended December 31, 2021 (our "2021 10-K").

In this Report, unless the context otherwise indicates, "we," "us" and "our" mean BWX Technologies, Inc. ("BWXT" or the "Company") and its consolidated subsidiaries.

Cautionary Statement Concerning Forward-Looking Statements

From time to time, our management or persons acting on our behalf make forward-looking statements to inform existing and potential security holders about our Company. Forward-looking statements include those statements that express a belief, expectation or intention, as well as those that are not statements of historical fact, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Statements and assumptions regarding expectations and projections of specific projects, our future backlog, revenues, income and capital spending, strategic investments, acquisitions or divestitures, return of capital activities, margin improvement initiatives or impacts of the novel strain of coronavirus ("COVID-19") pandemic are examples of forward-looking statements. Forward-looking statements are generally accompanied by words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "plan," "seek," "goal," "could," "intend," "may," "should" or other words that convey the uncertainty of future events or outcomes. In addition, sometimes we will specifically describe a statement as being a forward-looking statement and refer to this cautionary statement.

We have based our forward-looking statements on information currently available to us and our current expectations, estimates and projections about our Company, industries and business environment. We caution that these statements are not guarantees of future performance and you should not rely unduly on them as they involve risks, uncertainties and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. For example, the extent to which the COVID-19 pandemic will continue to impact our business will depend on future developments that are highly uncertain and cannot be predicted, including the potential recurrence of COVID-19, subsequent waves or strains or the emergence of similar diseases, the actions to contain the impact of such diseases and potential responses to such actions by our suppliers, contractors and employees. While our management considers these statements and assumptions to be reasonable, they are inherently subject to numerous factors, including potentially the risk factors described in Item 1A of our 2021 10-K, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements.

We have discussed many of these factors in more detail elsewhere in this Report, including under the heading "COVID-19 Assessment" of this Item 2 and Item 1A of our 2021 10-K. These factors are not necessarily all the factors that could affect us. Unpredictable or unanticipated factors we have not discussed in this Report or in our 2021 10-K could also have material adverse effects on actual results of matters that are the subject of our forward-looking statements. We do not intend to update or review any forward-looking statement or our description of important factors, whether as a result of new information, future events or otherwise, except as required by applicable laws.

General

We operate in two reportable segments: Government Operations and Commercial Operations. Our reportable segments reflect changes we made during the first quarter of 2022 to better align our businesses by their government and commercial nature, which reflects the manner in which our operating segment information is reported for purposes of assessing operating performance and allocating resources. Prior to 2022, we reported three segments: Nuclear Operations Group, Nuclear Power Group and Nuclear Services Group.

Our Government Operations segment consists of our legacy Nuclear Operations Group and Nuclear Services Group segments with certain research and development activities in the areas of advanced reactors and advanced manufacturing. Our Commercial Operations segment consists of our legacy Nuclear Power Group segment with certain research and development and commercialization activities in the areas of medical and industrial radioisotopes. Both segments now include research and development and certain commercialization activities associated with new technologies previously reported outside of our reportable segments. The change in our reportable segments had no impact on our previously reported consolidated results of operations, financial condition or cash flows. We have applied the change in reportable segments to previously reported historical financial information and related disclosures included in this Report.

In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We are currently exploring growth strategies across our segments to expand and complement our existing businesses. We would expect to fund these opportunities with cash generated from operations or by raising additional capital through debt, equity or some combination thereof.

Government Operations

The revenues of our Government Operations segment are largely a function of defense spending by the U.S. Government. Through this segment, we engineer, design and manufacture precision naval nuclear components, reactors and nuclear fuel for the U.S. Department of Energy ("DOE")/National Nuclear Safety Administration's Naval Nuclear Propulsion Program. In addition, we perform fabrication activities for missile launch tubes for U.S. Navy submarines and supply proprietary and sole-source valves, manifolds and fittings to global naval and ship customers. As a supplier of major nuclear components for certain U.S. Government programs, this segment is a significant participant in the defense industry.

This segment also provides various services to the U.S. Government by managing and operating high-consequence operations at U.S. nuclear weapons sites, national laboratories and manufacturing complexes. The revenues and equity in income of investees under these types of contracts are largely a function of spending of the U.S. Government and the performance scores we and our consortium partners earn in managing and operating these sites. With our specialized capabilities of full life-cycle management of special materials, facilities and technologies, we believe this segment is well-positioned to continue participating in the ongoing cleanup, operation and management of critical government-owned nuclear sites, laboratories and manufacturing complexes maintained by the DOE, NASA and other federal agencies.

Additionally, this segment also develops technology for a variety of applications, including advanced nuclear power sources, and offers complete advanced nuclear fuel and reactor design and engineering, licensing and manufacturing services for new advanced nuclear reactors.

Commercial Operations

Through this segment, we design and manufacture commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, as well as other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. This segment is a leading supplier of nuclear fuel, fuel handling systems, tooling delivery systems, nuclear-grade materials and precisely machined components, and related services for CANDU nuclear power plants. This segment also provides a variety of engineering and in-plant services and is a significant supplier to nuclear power utilities undergoing major refurbishment and plant life extension projects. Additionally, this segment is a global manufacturer and supplier of critical medical radioisotopes and radiopharmaceuticals.

Our Commercial Operations segment's overall activity primarily depends on the demand and competitiveness of nuclear energy and the demand for radioisotopes and radiopharmaceuticals for research, diagnostic and therapeutic uses. A significant portion of our Commercial Operations segment's operations depends on the timing of maintenance outages, the cyclical nature of capital expenditures and major refurbishment and life extension projects, as well as the demand for nuclear fuel and fuel handling equipment primarily in the Canadian market, which could cause variability in our financial results.

Acquisition of Dynamic Controls Limited and Citadel Capital Corporation

On April 11, 2022, our subsidiary BWXT Government Group, Inc. acquired all of the outstanding stock of U.K.-based Dynamic Controls Limited ("Dynamic") and U.S.-based Citadel Capital Corporation, along with its wholly-owned subsidiary, Cunico Corporation ("Cunico"). Dynamic and Cunico are suppliers of highly-engineered, proprietary valves, manifolds and fittings for global naval nuclear and diesel-electric submarines, surface warfare ships and commercial shipping vessels. These companies are reported as part of our Government Operations segment.

For additional information on the acquisition of Dynamic and Cunico, see Note 2 to our condensed consolidated financial statements included in this Report.

Critical Accounting Estimates

For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited condensed consolidated financial statements, see Item 7 of our 2021 10-K. There have been no material changes to our critical accounting policies and estimates during the nine months ended September 30, 2022.

Accounting for Contracts

On certain of our performance obligations, we recognize revenue over time. In accordance with FASB Topic Revenue from Contracts with Customers, we are required to estimate the total amount of costs on these performance obligations. As of September 30, 2022, we have provided for the estimated costs to complete all of our ongoing contracts. However, it is possible that current estimates could change due to unforeseen events, which could result in adjustments to overall contract revenues and costs. A principal risk on fixed-price contracts is that revenue from the customer is insufficient to cover increases in our costs. It is possible that current estimates could materially change for various reasons, including, but not limited to, fluctuations in the cost of labor, forecasted labor productivity or steel and other raw material prices. In some instances, we guarantee completion dates related to our projects or provide performance guarantees. Increases in costs on our fixed-price contracts could have a material adverse impact on our consolidated results of operations, financial condition and cash flows. Alternatively, reductions in overall contract costs at completion could materially improve our consolidated results of operations, financial condition and cash flows.

During the three and nine months ended September 30, 2022, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased (decreased) operating income by approximately $4.2 million and $(1.1) million, respectively. Included in these amounts are contract adjustments for cost overruns related to the manufacture of non-nuclear components being produced within our Government Operations segment. We have recognized a decrease in operating income of $11.3 million for the nine months ended September 30, 2022 related to this matter. These contract adjustments resulted in a decrease in earnings per share of $0.09 for the nine months ended September 30, 2022. We are exploring opportunities for recovery of cost overruns related to this project. During the three and nine months ended September 30, 2021, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $18.1 million and $27.8 million, respectively.

COVID-19 Assessment

General

We continue to monitor the COVID-19 pandemic and its impacts and potential impacts on our business. We continue to operate our facilities and have taken numerous precautions to mitigate exposure and protect the health and well-being of our workforce, including arranging for the vaccination of our workforce, where possible. To date, we have experienced localized operational challenges as a result of employee illness, quarantines and social distancing protocols, but the severity of these impacts has subsided significantly. Because developments related to the spread of COVID-19 and its impacts continue to change, it is difficult to predict any future impact at this time. Additionally, COVID-19 may also adversely impact our supply chain and other manufacturers, which could delay our receipt of essential goods and services. Any number of these potential risks could have a material adverse effect on our financial condition, results of operations and cash flows.

Government Assistance

On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief and Economic Security Act, which, among other things, provides employers an option to defer payroll tax payments for a limited period. As of September 30, 2022, we have deferred $10.7 million of payroll taxes which are due by January 2023. Additionally, on April 11, 2020, the Canadian Government enacted the Canada Emergency Wage Subsidy ("CEWS") under the COVID-19 Economic Response Plan to prevent large layoffs and help employers offset a portion of their employee salaries and wages for a limited period. During the nine months ended September 30, 2022, we recognized subsidies under the CEWS as an offset to operating expenses of $0.6 million, compared to $0.7 million and $4.9 million during the three and nine months ended September 30, 2021, respectively. The timeframe for submitting new claims under the CEWS ended in May 2022, and we do not expect to qualify for further assistance under this program.

Results of Operations – Three and Nine Months Ended September 30, 2022 vs. Three and Nine Months Ended September 30, 2021

Selected financial highlights are presented in the table below:

(In thousands)

REVENUES: Three Months Ended September 30, 2022 2021 $ Change Nine Months Ended September 30, 2022 2021 $ Change
Government Operations $422,521 $417,139 $5,382 $1,290,835 $1,245,911 $44,924
Commercial Operations 101,794 83,382 18,412 320,266 292,622 27,644
Eliminations (604) (1,794) 1,190 (2,444) (6,434) 3,990
$523,711 $498,727 $24,984 $1,608,657 $1,532,099 $76,558
OPERATING INCOME:
Government Operations $77,735 $87,542 $(9,807) $233,749 $238,658 $(4,909)
Commercial Operations 6,847 4,925 1,922 23,673 16,859 6,814
$84,582 $92,467 $(7,885) $257,422 $255,517 $1,905
Unallocated Corporate (4,704) (4,999) 295 (10,734) (11,884) 1,150
Total Operating Income $79,878 $87,468 $(7,590) $246,688 $243,633 $3,055

Consolidated Results of Operations

Three months ended September 30, 2022 vs. 2021

Consolidated revenues increased 5.0%, or $25.0 million, to $523.7 million in the three months ended September 30, 2022 compared to $498.7 million for the corresponding period of 2021, due to increases in our Government Operations and Commercial Operations segments of $5.4 million and $18.4 million, respectively.

Consolidated operating income decreased $7.6 million to $79.9 million in the three months ended September 30, 2022 compared to $87.5 million for the corresponding period of 2021. Operating income in our Government Operations segment decreased $9.8 million, which was partially offset by an increase in operating income in our Commercial Operations segment of $1.9 million and lower Unallocated Corporate expenses of $0.3 million when compared to the corresponding period of the prior year.

Nine months ended September 30, 2022 vs. 2021

Consolidated revenues increased 5.0%, or $76.6 million, to $1,608.7 million in the nine months ended September 30, 2022 compared to $1,532.1 million for the corresponding period of 2021, due to increases in our Government Operations and Commercial Operations segments of $44.9 million and $27.6 million, respectively.

Consolidated operating income increased $3.1 million to $246.7 million in the nine months ended September 30, 2022 compared to $243.6 million for the corresponding period of 2021. Operating income in our Commercial Operations segment increased by $6.8 million in addition to lower Unallocated Corporate expenses of $1.2 million when compared to the corresponding period of the prior year. These increases were partially offset by a decrease in operating income in our Government Operations segment of $4.9 million.

Government Operations

(In thousands)

Three Months Ended September 30, 2022 2021 $ Change Nine Months Ended September 30, 2022 2021 $ Change
Revenues $422,521 $417,139 $5,382 $1,290,835 $1,245,911 $44,924
Operating Income $77,735 $87,542 $(9,807) $233,749 $238,658 $(4,909)
% of Revenues 18.4% 21.0% 18.1% 19.2%

23

Three months ended September 30, 2022 vs. 2021

Revenues increased $5.4 million, or 1.3%, to $422.5 million in the three months ended September 30, 2022 compared to $417.1 million for the corresponding period of 2021. The increase was primarily related to additional volume in the manufacture of nuclear components for U.S. Government programs, which was partially offset by the timing of the procurement of certain long-lead materials when compared to the corresponding period of the prior year.

Operating income decreased $9.8 million to $77.7 million in the three months ended September 30, 2022 compared to $87.5 million for the corresponding period of 2021. The decrease was primarily related to lower levels of favorable contract adjustments of $14.1 million when compared to the corresponding period of the prior year. These decreases were partially offset by the operating income impact of the changes in revenues noted above in addition to an increase in operating income of $4.3 million associated with our joint venture activities, which include the Savannah River Site Integrated Mission Completion Contract that was awarded in 2021.

Nine months ended September 30, 2022 vs. 2021

Revenues increased 3.6%, or $44.9 million, to $1,290.8 million in the nine months ended September 30, 2022 compared to $1,245.9 million for the corresponding period of 2021. The increase was primarily related to additional volume in the manufacture of nuclear components for U.S. Government programs and the timing of the procurement of certain long-lead materials totaling $46.3 million when compared to the corresponding period of the prior year. We also experienced an increase in revenues of $9.1 million related to continued growth in design and engineering work executed by our advanced technologies business, particularly in the defense and space markets. These increases were offset by a reduction in volume related to missile tubes totaling $24.5 million.

Operating income decreased $4.9 million to $233.7 million in the nine months ended September 30, 2022 compared to $238.7 million for the corresponding period of 2021. The decrease was primarily related to lower levels of favorable contract adjustments of $34.1 million, inclusive of an $11.3 million adjustment related to the manufacture of non-nuclear components, which was recorded in the second quarter of 2022. These decreases were partially offset by the operating income impact of the changes in revenues noted above in addition to an increase in operating income of $9.3 million associated with our joint venture activities, which include the Savannah River Site Integrated Mission Completion Contract that was awarded in 2021.

Commercial Operations

(In thousands)

Three Months Ended September 30, 2022 2021 $ Change Nine Months Ended September 30, 2022 2021 $ Change
Revenues $101,794 $83,382 $18,412 $320,266 $292,622 $27,644
Operating Income $6,847 $4,925 $1,922 $23,673 $16,859 $6,814
% of Revenues 6.7% 5.9% 7.4% 5.8%

Three months ended September 30, 2022 vs. 2021

Revenues increased 22.1%, or $18.4 million, to $101.8 million in the three months ended September 30, 2022 compared to $83.4 million for the corresponding period of 2021. The increase was primarily related to higher levels of in-plant inspection, maintenance and modification services totaling $19.0 million as well as higher levels of revenue in our nuclear fuel handling business. These increases were partially offset by decreased revenues in our fuel fabrication business of $3.6 million when compared to the corresponding period of the prior year.

Operating income increased $1.9 million to $6.8 million in the three months ended September 30, 2022 compared to $4.9 million for the corresponding period of 2021, due to the operating income impact of the changes in revenues noted above as well as a favorable shift in our project and product line mix when compared to the corresponding period of the prior year. These operating income improvements were partially offset by a $2.0 million gain resulting from the settlement of contingent consideration associated with a prior acquisition, which was recorded in the prior year.

Nine months ended September 30, 2022 vs. 2021

Revenues increased 9.4%, or $27.6 million, to $320.3 million in the nine months ended September 30, 2022 compared to $292.6 million for the corresponding period of 2021. The increase was primarily related to higher levels of in-plant inspection, maintenance and modification services totaling $24.5 million as well as higher levels of revenue in our nuclear fuel handling and medical radioisotopes businesses. These increases were partially offset by decreased revenues in our fuel fabrication and parts manufacturing businesses when compared to the corresponding period of the prior year.

Operating income increased $6.8 million to $23.7 million in the nine months ended September 30, 2022 compared to $16.9 million for the corresponding period of 2021, due to the operating income impact of the changes in revenues noted above as well as a favorable shift in our project and product line mix when compared to the corresponding period of the prior year. In addition, we experienced higher levels of favorable contract adjustments when compared to the corresponding period of the prior year. These increases were partially offset by a $4.3 million decrease in wage subsidies we received under the CEWS to offset the effects of COVID-19 on our Canadian operations when compared to the corresponding period of the prior year, restructuring related costs of $1.8 million in addition to a $2.0 million gain resulting from the settlement of contingent consideration associated with a prior acquisition, which was recorded in the prior year.

Unallocated Corporate

Unallocated corporate expenses in the three months ended September 30, 2022 were relatively unchanged when compared to the corresponding period of 2021.

Unallocated corporate expenses decreased $1.2 million in the nine months ended September 30, 2022 compared to the corresponding period of 2021, primarily due to a decrease in healthcare costs, which were partially offset by an increase in legal and consulting costs associated with due diligence activities.

Provision for Income Taxes

(In thousands)

Three Months Ended September 30, 2022 2021 $ Change Nine Months Ended September 30, 2022 2021 $ Change
Income before Provision for Income Taxes $82,022 $77,769 $4,253 $257,569 $248,593 $8,976
Provision for Income Taxes $20,185 $17,611 $2,574 $61,977 $59,211 $2,766
Effective Tax Rate 24.6% 22.6% 24.1% 23.8%

We primarily operate in the U.S., Canada, and the U.K. and recognize our U.S. income tax provision based on the U.S. federal statutory rate of 21%, our Canadian tax provision based on the Canadian local statutory rate of approximately 25%, and our U.K. tax provision based on the U.K. local statutory rate of 19%.

Our effective tax rate for the three months ended September 30, 2022 was 24.6% as compared to 22.6% for the three months ended September 30, 2021. The effective tax rate for the three months ending September 30, 2022 was higher than the effective tax rate for the three months ending September 30, 2021 primarily due to a decrease in eligible research and development expenses. Our effective tax rate for the nine months ended September 30, 2022 was 24.1% as compared to 23.8% for the nine months ended September 30, 2021. The effective tax rates for the three and nine months ended September 30, 2022 and 2021 were higher than the U.S. corporate income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings.

Backlog

Backlog represents the dollar amount of revenue we expect to recognize in the future from contracts awarded and in progress. Not all of our expected revenue from a contract award is recorded in backlog for a variety of reasons, including that some projects are awarded and completed within the same reporting period.

Our backlog is equal to our remaining performance obligations under contracts that meet the criteria in FASB Topic Revenue from Contracts with Customers, as discussed in Note 3 to our condensed consolidated financial statements included in this Report. It is possible that our methodology for determining backlog may not be comparable to methods used by other companies.

We are subject to the budgetary and appropriations cycle of the U.S. Government as it relates to our Government Operations segment. Backlog may not be indicative of future operating results, and projects in our backlog may be cancelled, modified or otherwise altered by customers.

September 30, 2022 (In approximate millions) December 31, 2021
Government Operations $3,686 $4,532
Commercial Operations 633 644
Total Backlog $4,319 $5,176

We do not include the value of our unconsolidated joint venture contracts in backlog. These unconsolidated joint ventures are included in our Government Operations segment.

At September 30, 2022, our ending backlog was $4,318.9 million, which included $104.3 million of unfunded backlog related to U.S. Government contracts. We expect to recognize approximately 46% of the revenue associated with our backlog by the end of 2023, with the remainder to be recognized thereafter.

Major new awards from the U.S. Government are typically received following Congressional approval of the budget for the U.S. Government's next fiscal year, which starts October 1, and may not be awarded to us before the end of the calendar year. Due to the fact that most contracts awarded by the U.S. Government are subject to these annual funding approvals, the total values of the underlying programs are significantly larger.

The value of unexercised options excluded from backlog as of September 30, 2022, was approximately $0.4 billion, which is expected to be awarded in annual installments through 2024, subject to annual Congressional appropriations.

Liquidity and Capital Resources

Credit Facility

On March 24, 2020, we entered into an Amendment No. 1 to Credit Agreement, which amended the Credit Agreement dated as of May 24, 2018 (as amended, the "Credit Facility") with Wells Fargo Bank, N.A., as administrative agent, and the other lenders party thereto. The Credit Facility provides for a $750 million senior secured revolving credit facility (the "Revolving Credit Facility"). All obligations under the Revolving Credit Facility were scheduled to mature on March 24, 2025. The proceeds of loans under the Revolving Credit Facility were available for working capital needs, permitted acquisitions and other general corporate purposes.

The Credit Facility allowed for additional parties to become lenders and, subject to certain conditions, for the increase of the commitments under the Credit Facility, subject to an aggregate maximum for all additional commitments of (1) the greater of (a) $250 million and (b) 65% of EBITDA, as defined in the Credit Facility, for the last four full fiscal quarters, plus (2) all voluntary prepayments of the term loans, plus (3) additional amounts provided the Company was in compliance with a pro forma first lien leverage ratio test of less than or equal to 2.50 to 1.00.

The Company's obligations under the Credit Facility were guaranteed, subject to certain exceptions, by substantially all of the Company's present and future wholly owned domestic restricted subsidiaries. The Credit Facility was secured by first-priority liens on certain assets owned by the Company and its subsidiary guarantors (other than the majority of its subsidiaries comprising its Government Operations segment).

The Revolving Credit Facility required interest payments on revolving loans on a periodic basis until maturity. We could prepay all loans under the Credit Facility at any time without premium or penalty (other than customary Eurocurrency breakage costs), subject to notice requirements.

The Credit Facility included financial covenants that were tested on a quarterly basis, based on the rolling four-quarter period that ended on the last day of each fiscal quarter. The maximum permitted leverage ratio was 4.00 to 1.00, which could be increased to 4.50 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated interest coverage ratio was 3.00 to 1.00. In addition, the Credit Facility contained various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales. As of September 30, 2022, we were in compliance with all covenants set forth in the Credit Facility.

Outstanding loans under the Revolving Credit Facility bore interest at our option at either (1) the Eurocurrency rate plus a margin ranging from 1.0% to 1.75% per year or (2) the base rate plus a margin ranging from 0.0% to 0.75% per year. We were charged a commitment fee on the unused portion of the Revolving Credit Facility, and that fee ranged from 0.15% to 0.225% per year. Additionally, we were charged a letter of credit fee of between 1.0% and 1.75% per year with respect to the amount of each financial letter of credit issued under the Credit Facility, and a letter of credit fee of between 0.75% and 1.05% per year with respect to the amount of each performance letter of credit issued under the Credit Facility. The applicable margin for loans, the commitment fee and the letter of credit fees set forth above varied quarterly based on our leverage ratio. Based on the leverage ratio applicable at September 30, 2022, the margin for Eurocurrency rate and base rate revolving loans was 1.50% and 0.50%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.50% and 0.90%, respectively, and the commitment fee for the unused portion of the Revolving Credit Facility was 0.20%.

As of September 30, 2022, borrowings and letters of credit issued under the Revolving Credit Facility totaled $550.0 million and $37.1 million, respectively. As a result, as of September 30, 2022 we had $162.9 million available under the Revolving Credit Facility for borrowings and to meet letter of credit requirements. As of September 30, 2022, the interest rate on outstanding borrowings under our Credit Facility was 4.27%.

The Credit Facility generally includes customary events of default for a secured credit facility. Under the Credit Facility, (1) if an event of default relating to bankruptcy or other insolvency events occurs with respect to the Company, all related obligations would immediately become due and payable; (2) if any other event of default exists, the lenders would be permitted to accelerate the maturity of the related obligations outstanding; and (3) if any event of default exists, the lenders would be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.

If any default occurs under the Credit Facility, or if we were unable to make any of the representations and warranties in the Credit Facility, we would be unable to borrow funds or have letters of credit issued under the Credit Facility.

Amended and Restated Credit Agreement

On October 12, 2022, we entered into an Amended and Restated Credit Agreement (the "New Credit Facility") with Wells Fargo Bank, National Association, as administrative agent, and the other lenders party thereto, which amended and restated the Credit Facility. The New Credit Facility includes a $750 million senior secured revolving credit facility (the "New Revolving Credit Facility") and a $250 million senior secured term A loan (the "New Term Loan"). The New Revolving Credit Facility and the New Term Loan are scheduled to mature on October 12, 2027. All proceeds from the New Term Loan were used to repay outstanding indebtedness under the Credit Facility.

As of October 12, 2022, outstanding borrowings under the New Credit Facility totaled $570.0 million, comprising $250.0 million under the New Term Loan and $320.0 million under the New Revolving Credit Facility, and letters of credit issued under the New Revolving Credit Facility totaled $37.1 million. As a result, as of October 12, 2022, the Company had $392.9 million available under the New Revolving Credit Facility for borrowings and to meet letter of credit requirements.

Senior Notes due 2028

We issued $400 million aggregate principal amount of 4.125% senior notes due 2028 (the "Senior Notes due 2028") pursuant to an indenture dated June 12, 2020 (the "2020 Indenture"), among the Company, certain of our subsidiaries, as guarantors, and U.S. Bank Trust Company, National Association (formerly known as U.S. Bank National Association) ("U.S. Bank"), as trustee. The Senior Notes due 2028 are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Credit Facility.

Interest on the Senior Notes due 2028 is payable semi-annually in cash in arrears on June 30 and December 30 of each year at a rate of 4.125% per annum. The Senior Notes due 2028 will mature on June 30, 2028.

We may redeem the Senior Notes due 2028, in whole or in part, at any time on or after June 30, 2023 at a redemption price equal to (i) 102.063% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on June 30, 2023, (ii) 101.031% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on June 30, 2024 and (iii) 100.0% of the principal amount to be redeemed if the redemption occurs on or after June 30, 2025, in each case plus accrued and unpaid interest, if any, to, but excluding, the redemption date. At any time prior to June 30, 2023, we may also redeem up to 40.0% of the Senior Notes due 2028 with net cash proceeds of certain equity offerings at a redemption price equal to 104.125% of the principal amount of the Senior Notes due 2028 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to June 30, 2023, we may redeem the Senior Notes due 2028, in whole or in part, at a redemption price equal to 100.0% of the principal amount of the Senior Notes due 2028 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable "make-whole" premium.

The 2020 Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the 2020 Indenture or the Senior Notes due 2028 and certain provisions related to bankruptcy events. The 2020 Indenture also contains customary negative covenants. As of September 30, 2022, we were in compliance with all covenants set forth in the 2020 Indenture and the Senior Notes due 2028.

Senior Notes due 2029

We issued $400 million aggregate principal amount of 4.125% senior notes due 2029 (the "Senior Notes due 2029") pursuant to an indenture dated April 13, 2021 (the "2021 Indenture"), among the Company, certain of our subsidiaries, as guarantors, and U.S. Bank, as trustee. The Senior Notes due 2029 are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Credit Facility.

Interest on the Senior Notes due 2029 is payable semi-annually in cash in arrears on April 15 and October 15 of each year, at a rate of 4.125% per annum. The Senior Notes due 2029 will mature on April 15, 2029.

We may redeem the Senior Notes due 2029, in whole or in part, at any time on or after April 15, 2024 at a redemption price equal to (i) 102.063% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on April 15, 2024, (ii) 101.031% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on April 15, 2025 and (iii) 100.0% of the principal amount to be redeemed if the redemption occurs on or after April 15, 2026, in each case plus accrued and unpaid interest, if any, to, but excluding, the redemption date. At any time prior to April 15, 2024, we may also redeem up to 40.0% of the Senior Notes due 2029 with net cash proceeds of certain equity offerings at a redemption price equal to 104.125% of the principal amount of the Senior Notes due 2029 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to April 15, 2024, we may redeem the Senior Notes due 2029, in whole or in part, at a redemption price equal to 100.0% of the principal amount of the Senior Notes due 2029 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable "make-whole" premium.

The 2021 Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the 2021 Indenture or the Senior Notes due 2029 and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants. As of September 30, 2022, we were in compliance with all covenants set forth in the 2021 Indenture and the Senior Notes due 2029.

Other Arrangements

We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion, and the bonding facilities generally permit the surety, in its sole discretion, to terminate the facility or demand collateral. Although there can be no assurance that we will maintain our surety bonding capacity, we believe our current capacity is adequate to support our existing requirements for the next twelve months. In addition, these bonds generally indemnify the beneficiaries should we fail to perform our obligations under the applicable agreements. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of September 30, 2022, bonds issued and outstanding under these arrangements totaled approximately $112.7 million.

Long-term Benefit Obligations

As of September 30, 2022, we had underfunded defined benefit pension and postretirement benefit plans with obligations totaling approximately $74.2 million. These long-term liabilities are expected to require use of our resources to satisfy future funding obligations. Based largely on statutory funding requirements, we expect to make contributions of approximately $8.0 million for the remainder of 2022 related to our pension and postretirement plans. We may also make additional contributions based on a variety of factors including, but not limited to, tax planning, evaluation of funded status and risk mitigation strategies.

Other

Cash, Cash Equivalents, Restricted Cash and Investments

Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of September 30, 2022 and December 31, 2021 were as follows:

(In thousands)

September 30, 2022 December 31, 2021
Domestic $43,030 $39,128
Foreign 25,486 14,016
Total $68,516 $53,144

Our working capital increased by $128.8 million to $442.9 million at September 30, 2022 from $314.1 million at December 31, 2021, primarily attributable to an increase in cash and cash equivalents as well as the timing of project cash flows and vendor payments.

Our net cash provided by operating activities decreased by $88.5 million to $137.0 million in the nine months ended September 30, 2022, compared to $225.6 million in the nine months ended September 30, 2021. The decrease in cash provided by operating activities was primarily attributable to an $88.7 million customer payment delayed until the first quarter of 2021, which was originally expected in 2020.

Our net cash used in investing activities decreased by $41.0 million to $193.1 million in the nine months ended September 30, 2022, compared to $234.1 million in the nine months ended September 30, 2021. The decrease in cash used in investing activities was primarily attributable to a decrease in purchases of property, plant and equipment of $102.1 million, which was partially offset by the $47.3 million acquisition of Dynamic and Cunico as well as a $11.5 million increase in investments in equity method investees in the nine months ended September 30, 2022.

Our net cash provided by financing activities increased by $40.9 million to $76.3 million in the nine months ended September 30, 2022, compared to $35.4 million in the nine months ended September 30, 2021. The increase in cash provided by financing activities was primarily attributable to a reduction in repurchases of common stock of $165.8 million when compared to the corresponding period of the prior year and the repayment of bank overdrafts of $88.7 million in the nine months ended September 30, 2021. This increase was partially offset by a reduction in net borrowings of long-term debt of $240.0 million when compared to the corresponding period of the prior year.

At September 30, 2022, we had restricted cash and cash equivalents totaling $5.5 million, $2.6 million of which was held for future decommissioning of facilities (which is included in other assets on our condensed consolidated balance sheets) and $2.9 million of which was held to meet reinsurance reserve requirements of our captive insurer.

At September 30, 2022, we had short-term and long-term investments with a fair value of $11.6 million. Our investment portfolio consists primarily of U.S. Government and agency securities, corporate bonds and mutual funds. Our debt securities are carried at fair value and are either classified as trading, with unrealized gains and losses reported in earnings, or as available-for-sale, with unrealized gains and losses, net of tax, being reported as a component of other comprehensive income. Our equity securities are carried at fair value with the unrealized gains and losses reported in earnings.

Cash Requirements

Our cash requirements have not changed materially from those disclosed in Item 7 of our 2021 10-K. We believe we have sufficient cash and cash equivalents and borrowing capacity, along with cash generated from operations and continued access to debt markets, to satisfy our cash requirements for the next 12 months and beyond.

Controls and procedures

As filed, 1,956 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the

Securities and Exchange Commission ("SEC") under the Exchange Act). This evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Our disclosure controls and procedures were developed through a process in which our management applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding the control objectives. You should note that the design of any system of disclosure controls and procedures is based in part upon various assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. Based on the evaluation referred to above, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures are effective as of September 30, 2022 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding disclosure. There has been no change in our internal control over financial reporting during the three months ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

Risk factors

As filed, 309 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information in this Report, the other factors presented in Item 1A of our 2021 10-K are some of the factors that could materially affect our business, financial condition or future results. There have been no material changes to our risk factors from those disclosed in our 2021 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-01 to 2022-09-30$523.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-09-30$1.61bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-01 to 2022-09-30$399.3mus-gaap:CostOfRevenue
Cost of revenue9 months2022-01-01 to 2022-09-30$1.22bnus-gaap:CostOfRevenue
Research and development3 months2022-07-01 to 2022-09-30$1.4mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2022-01-01 to 2022-09-30$7.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-07-01 to 2022-09-30$58.2mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-01-01 to 2022-09-30$173.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-07-01 to 2022-09-30$79.9mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30$246.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$9.6mus-gaap:InterestExpense
Interest expense9 months2022-01-01 to 2022-09-30$25.0mus-gaap:InterestExpense
Income tax3 months2022-07-01 to 2022-09-30$20.2mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-09-30$62.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-01 to 2022-09-30$61.6mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-09-30$195.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30$0.67us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30$2.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30$0.67us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$2.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-3091,655,536 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-3091,665,383 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30$137.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-01-01 to 2022-09-30$134.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2022-01-01 to 2022-09-30$60.9mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2022-01-01 to 2022-09-30$20.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-09-30$51.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$849.7mus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$2.67bnus-gaap:Assets
Current liabilitiesAt period end2022-09-30$406.8mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2022-09-30$1.34bnus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-09-30$712.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001486957-22-000035. Last ingested by Listed: Nov 14, 2026, 19:14 ET. Listed shows no prices and gives no investment advice.